News
Roche, Genentech to Develop $700M Pharmaceutical Manufacturing Facility in Holly Springs, North Carolina
Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles southwest of Raleigh.
Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...
About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...
Pharmaceutical Technology on MSN1d
Roche plans $700m manufacturing plant in the USThe new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.
Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...
The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.
Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback